ArticleBMC genomics2018

Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.

Jean M Winter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.